Embryonic Tumours of the Central Nervous System

Overview

Journal Clin Transl Oncol

Specialty Oncology

Date 2005 Jun 18

PMID 15960935

Citations 1

Authors

Aurora Navajas Gutierrez

Ana Fernandez-Teijeiro Alvarez

Affiliations

Soon will be listed here.

Citing Articles

Evidence in medulloblastomas.

Navajas A, Giralt J Clin Transl Oncol. 2010; 12(4):271-7.

PMID: 20462836 DOI: 10.1007/s12094-010-0503-y.

References

Gilbertson R, Wickramasinghe C, Hernan R, Balaji V, Hunt D, Crolla J . Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer. 2001; 85(5):705-12. PMC: 2364121. DOI: 10.1054/bjoc.2001.1987. View

Zeltzer P, Boyett J, Finlay J, Albright A, RORKE L, Milstein J . Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol. 1999; 17(3):832-45. DOI: 10.1200/JCO.1999.17.3.832. View

Mulhern R, Palmer S, Reddick W, Glass J, Kun L, Taylor J . Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol. 2001; 19(2):472-9. DOI: 10.1200/JCO.2001.19.2.472. View

Grotzer M, Janss A, Fung K, Biegel J, Sutton L, RORKE L . TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol. 2000; 18(5):1027-35. DOI: 10.1200/JCO.2000.18.5.1027. View

Tait D, BLOOM H, Lemerle J . Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer. 1990; 26(4):464-9. View

Kalifa C, Valteau D, Pizer B, Vassal G, Grill J, Hartmann O . High-dose chemotherapy in childhood brain tumours. Childs Nerv Syst. 1999; 15(10):498-505. DOI: 10.1007/s003810050538. View

Kuhl J . Modern treatment strategies in medulloblastoma. Childs Nerv Syst. 1998; 14(1-2):2-5. DOI: 10.1007/s003810050164. View

Eberhart C, Burger P . Anaplasia and grading in medulloblastomas. Brain Pathol. 2003; 13(3):376-85. PMC: 8096053. DOI: 10.1111/j.1750-3639.2003.tb00037.x. View

Fernandez-Teijeiro A, Betensky R, Sturla L, Kim J, Tamayo P, Pomeroy S . Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. J Clin Oncol. 2004; 22(6):994-8. DOI: 10.1200/JCO.2004.03.036. View

10.

Palmer S, Goloubeva O, Reddick W, Glass J, Gajjar A, Kun L . Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. J Clin Oncol. 2001; 19(8):2302-8. DOI: 10.1200/JCO.2001.19.8.2302. View

11.

Eberhart C, Kepner J, Goldthwaite P, Kun L, Duffner P, Friedman H . Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer. 2002; 94(2):552-60. DOI: 10.1002/cncr.10189. View

12.

Chi S, Gardner S, Levy A, Knopp E, Miller D, Wisoff J . Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol. 2004; 22(24):4881-7. DOI: 10.1200/JCO.2004.12.126. View

13.

Rood B, MacDonald T, Packer R . Current treatment of medulloblastoma: recent advances and future challenges. Semin Oncol. 2004; 31(5):666-75. DOI: 10.1053/j.seminoncol.2004.07.009. View

14.

Timmermann B, Kortmann R, Kuhl J, Meisner C, Dieckmann K, Pietsch T . Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. J Clin Oncol. 2002; 20(3):842-9. DOI: 10.1200/JCO.2002.20.3.842. View

15.

Giangaspero F, Rigobello L, Badiali M, Loda M, Andreini L, Basso G . Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol. 1992; 16(7):687-93. View

16.

Grill J, Renaux V, Bulteau C, Viguier D, Sainte-Rose C, Dellatolas G . Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys. 1999; 45(1):137-45. DOI: 10.1016/s0360-3016(99)00177-7. View

17.

Duffner P, Horowitz M, Krischer J, Burger P, Cohen M, Sanford R . The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol. 2001; 1(2):152-61. PMC: 1920752. DOI: 10.1093/neuonc/1.2.152. View

18.

Packer R, Goldwein J, Nicholson H, Vezina L, Allen J, Ris M . Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol. 1999; 17(7):2127-36. DOI: 10.1200/JCO.1999.17.7.2127. View

19.

Peet A, Leach M, Pinkerton C, Price P, Williams S, Grundy R . The development of functional imaging in the diagnosis, management and understanding of childhood brain tumours. Pediatr Blood Cancer. 2004; 44(2):103-13. DOI: 10.1002/pbc.20229. View

20.

Slavc I, Schuller E, Czech T, Hainfellner J, Seidl R, Dieckmann K . Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination. J Neurooncol. 1998; 38(2-3):213-8. DOI: 10.1023/a:1005940405165. View